Avidity Biosciences (NASDAQ:RNA) has announced new data from its clinical trials evaluating the experimental treatment del-zota for Duchenne muscular dystrophy. After one year of continuous treatment, participants showed not only a halt in disease progression, but also measurable improvements compared to their ...

Join for a 100% Risk-Free trial and see if our proven method can help you too. You do not need to pay for the costly lessons from the market itself.Sensor Unlimited contributes to the investing group Envision Early Retirement which is led by Sensor Unlimited. They offer proven solutions to generate both high income and high growth with isolated risks through dynamic asset allocation. Features include: two model portfolios - one for short-term survival/withdrawal and one for aggressive long-term growth, dire ...

Join for a 100% Risk-Free trial and see if our proven method can help you too. You do not need to pay for the costly lessons from the market itself.Sensor Unlimited contributes to the investing group Envision Early Retirement which is led by Sensor Unlimited. They offer proven solutions to generate both high income and high growth with isolated risks through dynamic asset allocation. Features include: two model portfolios - one for short-term survival/withdrawal and one for aggressive long-term growth, dire ...

PLANO, TX / ACCESS Newswire / September 11, 2025 / BGSF, Inc. (NYSE:BGSF) ("BGSF" or "the Company"), a leading provider of workforce solutions for the specialized property management industry, today announced that its Board of Directors has authorized and declared a special cash dividend of $2.00 per share of the Company's common stock, par value $0.01 ("Common Stock"), payable on September 30, 2025, to the holders of record of all of the issued and outstanding shares of Common Stock as of the close of busi ...

SL Green Realty (NYSE:SLG) was trading higher as Citi Research upgraded the office REIT on the strength of the New York office market and improving NY office transaction environment. Shares were +2.64% Thursday post-market to $65.00. "In addition, the recent underperformance ...

Adobe raised its fiscal 2025 revenue and profit forecasts on Thursday, signaling strong demand for its design software and increased monetization of its artificial intelligence tools. ...

Fall has arrived, and with the crisp breezes and falling leaves comes a less pleasant reminder: the end of the tax year. Investors and advisors all must contend with paying the tax man for their previous income and gains. A variety of options exist, however, to offset those taxes, from tax loss harvesting to tax-exempt muni bonds. One ETF, the T. Rowe Price Intermediate Municipal Income ETF (TAXE), stands out in the later tax-exempt ETFs category for its active approach, leaning on T. Rowe Price's research ...

Northrop Grumman (NYSE:NOC) handed over a second B-21 Raider stealth bomber to the U.S. Air Force, marking another step toward preparing the next-generation aircraft for service. The new bomber arrived at Edwards Air Force Base in California, where it will expand ...

Adobe (NASDAQ:ADBE) shares edged higher after reporting its third quarter fiscal 2025 financial results that surpassed estimates across the board post-market on Thursday. The company reported annual recurring revenue related to artificial intelligence applications had surpassed $5B. For the quarter ...

With a year-to-date (YTD) gain of nearly 70%, Alibaba's (BABA) stock has outperformed the markets significantly this year. The Chinese tech giant, which was once the face of China’s brutal tech crackdown, is now back in the government’s good graces as the country backs its domestic companies amid the artificial intelligence (AI) upmanship between the U.S. and China. Alibaba is among the prominent AI plays in China and has attracted interest from investors seeking to capitalize on the China AI story. In my ...